
Abirab Injection
Marketer
Abiba Pharmacia Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Abirab Injection
Stomach acid reduction is the primary function of Xylinject, a medication administered intravenously by medical professionals. Indicated for various gastrointestinal disorders marked by excessive acid production, including acid reflux, indigestion, peptic ulcers, and other related conditions, Xylinject offers rapid symptom relief. Its prophylactic use extends to preventing stress ulcers in critically ill patients and mitigating aspiration risks during anesthesia. A proton pump inhibitor (PPI), Xylinject's dosage is determined by individual needs and response, with treatment duration set by the physician. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom improvement. Lifestyle modifications, such as consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Commonly reported mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant immediate medical consultation. Prolonged use, particularly exceeding one year, may increase the risk of bone fractures, especially at higher doses. The physician may recommend preventative measures against osteoporosis, such as calcium and vitamin D supplementation. Hypomagnesemia (low magnesium levels) has been observed after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and cardiac arrhythmias. Magnesium level monitoring may be implemented to mitigate this risk. Xylinject is contraindicated for individuals with severe hepatic impairment, those concurrently using HIV medications, those with a history of similar medication allergies, and those with pre-existing osteoporosis. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Operation of machinery or driving should be avoided if dizziness or drowsiness occurs.
Uses of Abirab Injection
Managing acid reflux and peptic ulcers
Major Benefits of Abirab Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Abirab Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Abirab Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Abirab Injection works:
Abirab Injection, a proton pump inhibitor, decreases stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
It is recommended to avoid alcohol while using Abirab Injection. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Abirab Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Abirab Injection while breastfeeding is likely unsafe. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Abirab Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Abirab Injection presents no safety concerns for use in patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Patients with severe hepatic impairment should use Abirab Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Abirab Injection :
Should you forget a scheduled Abirab Injection, seek your physician's advice.
Facts to Know About Abirab Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide |
| Addictive | None. |
| Medication Classification | Digestive system |
| Mechanism of Action | Gastric acid secretion suppressants |
